|
1
|
American Cancer Society. Cancer Facts and
Figures 2015. American Cancer Society; Atlanta: 2015, http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf.
|
|
2
|
Boffetta P and Trichopoulos D: Cancer of
the lung, larynx and pleura. Cancer Epidemiology. Adami H, Hunter D
and Trichopolous D: Oxford University Press; New York, NY: 2008
|
|
3
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szabo E, Mao JT, Lam S, Reid ME and Keith
RL: Chemoprevention of lung cancer: Diagnosis and management of
lung cancer. 3rd edition. American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines. 2013, http://www.guideline.gov/content.aspx?id=46162.
|
|
5
|
Anthonisen NR, Skeans MA, Wise RA,
Manfreda J, Kanner RE and Connett JE: Lung Health Study Research
Group: The effects of a smoking cessation intervention on 14.5-year
mortality: A randomized clinical trial. Ann Intern Med.
142:233–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
World Cancer Research Fund/American
Institute for Cancer Research. Food, Nutrition, Physical Activity,
and the Prevention of Cancer: a Global Perspective. AICR;
Washington, DC: 2007, http://www.dietandcancerreport.org/cancer_resource_center/downloads/Second_Expert_Report_full.pdf.
|
|
7
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balkwill F: Tumour necrosis factor and
cancer. Nat Rev Cancer. 9:361–371. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thorgeirsson TE, Geller F, Sulem P, Rafnar
T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson
H, Ingason A, et al: A variant associated with nicotine dependence,
lung cancer and peripheral arterial disease. Nature. 452:638–642.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bach PB, Kattan MW, Thornquist MD, Kris
MG, Tate RC, Barnett MJ, Hsieh LJ and Begg CB: Variations in lung
cancer risk among smokers. J Natl Cancer Inst. 95:470–478. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amos CI, Wu X, Broderick P, Gorlov IP, Gu
J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al:
Genome-wide association scan of tag SNPs identifies a
susceptibility locus for lung cancer at 15q25.1. Nat Genet.
40:616–622. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Siemes C, Visser LE, Coebergh JW, Splinter
TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA and Stricker
BH: C-reactive protein levels, variation in the C-reactive protein
gene, and cancer risk: The Rotterdam Study. J Clin Oncol.
24:5216–5222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang YT, Lin X, Liu Y, Chirieac LR,
McGovern R, Wain J, Heist R, Skaug V, Zienolddiny S, Haugen A, et
al: Cigarette smoking increases copy number alterations in
nonsmall-cell lung cancer. Proc Natl Acad Sci USA. 108:16345–16350.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Allin KH and Nordestgaard BG: Elevated
C-reactive protein in the diagnosis, prognosis, and cause of
cancer. Crit Rev Clin Lab Sci. 48:155–170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Volonakis J: Human C-reactive protein:
expression, structure, and function. Mol Immunol. 38:189–197. 2001.
View Article : Google Scholar
|
|
18
|
Vagulienė N, Žemaitis M, Miliauskas S,
Urbonienė D, Šitkauskienė B and Sakalauskas R: Comparison of
C-reactive protein levels in patients with lung cancer and chronic
obstructive pulmonary disease. Medicina (Kaunas). 47:421–427.
2011.
|
|
19
|
Heikkila K, Ebrahim S and Lawlor DA: A
systematic review of the association between circulating
concentrations of C-reactive protein and cancer. J Epidemiol
Community Health. 61:824–833. 2007. View Article : Google Scholar
|
|
20
|
Chaturvedi AK, Caporaso NE, Katki HA, Wong
HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ and Engels EA:
C-reactive protein and risk of lung cancer. J Clin Oncol.
28:2719–2726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gunter EW and McQuillan G: Quality control
in planning and operating the laboratory component for the Third
National Health and Nutrition Examination Survey. J Nutr. 120(Suppl
11): 1451–1454. 1990.PubMed/NCBI
|
|
22
|
Tsilidis KK, Branchini C, Guallar E,
Helzlsouer KJ, Erlinger TP and Platz EA: C-reactive protein and
colorectal cancer risk: A systematic review of prospective studies.
Int J Cancer. 123:1133–1140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shiels MS, Pfeiffer RM, Hildesheim A,
Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G,
Caporaso NE, et al: Circulating inflammation markers and
prospective risk for lung cancer. J Natl Cancer Inst.
105:1871–1880. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Allin KH, Bojesen SE and Nordestgaard BG:
Baseline C-reactive protein is associated with incident cancer and
survival in patients with cancer. J Clin Oncol. 27:2217–2224. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Il'yasova D, Colbert LH, Harris TB, Newman
AB, Bauer DC, Satterfield S and Kritchevsky SB: Circulating levels
of inflammatory markers and cancer risk in the health aging and
body composition cohort. Cancer Epidemiol Biomarkers Prev.
14:2413–2418. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Trichopoulos D, Psaltopoulou T, Orfanos P,
Trichopoulou A and Boffetta P: Plasma C-reactive protein and risk
of cancer: A prospective study from Greece. Cancer Epidemiol
Biomarkers Prev. 15:381–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
NCHS Plan & Operation of the Third
National Health and Nutrition Examination Survey, 1988–94. Vital
and Health Statistics. 32:1–416. 1992.
|
|
28
|
U.S. Department of Health and Human
Services. Third National Health and Nutrition Examination Survey -
NHANES III Examination Data File. Public Use Data File
Documentation Number 76200. Centers for Disease Control and
Prevention; Hyattsville, MD: 1996, http://wonder.cdc.gov/wonder/sci_data/surveys/hanes/hanes3/type_txt/exam1.asp.
|
|
29
|
Madans JH and Hunter EL: Improving and
integrating data systems for public health surveillance. J Public
Health Manag Pract. 2:42–44. 1996. View Article : Google Scholar
|
|
30
|
NCHS (National Center for Health
Statistics). NHANES III Mortality File: Matching Methodology. 2005,
ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/datalinkage/linked_mortality/archived_files/mort_2004_release/matching_methodology_nhanes3_final.pdfftpsimpleftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/datalinkage/linked_mortality/archived_files/mort_2004_release/matching_methodology_nhanes3_final.pdf.
|
|
31
|
NCHS National Health and Nutrition
Examination Survey III Linked Mortality File. http://www.cdc.gov/nchs/data_access/data_linkage/mortality/nhanes3_linkage.htm.
Accessed October 15, 20112006
|
|
32
|
Imayama I, Ulrich CM, Alfano CM, Wang C,
Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong
A, et al: Effects of a caloric restriction weight loss diet and
exercise on inflammatory biomarkers in overweight/obese
postmenopausal women: A randomized controlled trial. Cancer Res.
72:2314–2326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pearson TA, Mensah GA, Alexander RW,
Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y,
Myers GL, et al: Centers for Disease Control and Prevention;
American Heart Association: Markers of inflammation and
cardiovascular disease: application to clinical and public health
practice: A statement for healthcare professionals from the Centers
for Disease Control and Prevention and the American Heart
Association. Circulation. 107:499–511. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
World Health Organization. Physical
status: the use and interpretation of anthopometry. Report of a WHO
expert committee. (WHO Technical Report Series 854). World Health
Organization; Geneva: 1995, http://www.who.int/childgrowth/publications/physical_status/en/.
|
|
35
|
Guo YZ, Pan L, Du CJ, Ren DQ and Xie XM:
Association between C-reactive protein and risk of cancer: A
meta-analysis of prospective cohort studies. Asian Pac J Cancer
Prev. 14:243–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
López-Campos JL, Calero C, Rojano B,
López-Porras M, Sáenz-Coronilla J, Blanco AI, Sánchez-López V,
Tobar D, Montes-Worboys A and Arellano E: C-reactive protein and
serum amyloid a overexpression in lung tissues of chronic
obstructive pulmonary disease patients: A case-control study. Int J
Med Sci. 10:938–947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wynder EL and Graham EA: Tobacco smoking
as a possible etiologic factor in bronchiogenic carcinoma; a study
of 684 proved cases. J Am Med Assoc. 143:329–336. 1950. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Howlader N, Noone AM, Krapcho M, et al:
SEER Cancer Statistics Review, 1975–2008. National Cancer
Institute; Bethesda, MD: 2010, http://seer.cancer.gov/archive/csr/1975_2008/.
|
|
39
|
Smith L, Brinton LA, Spitz MR, Lam TK,
Park Y, Hollenbeck AR, Freedman ND and Gierach GL: Body mass index
and risk of lung cancer among never, former, and current smokers. J
Natl Cancer Inst. 104:778–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khera A, McGuire DK, Murphy SA, Stanek HG,
Das SR, Vongpatanasin W, Wians FH Jr, Grundy SM and de Lemos JA:
Race and gender differences in C-reactive protein levels. J Am Coll
Cardiol. 46:464–469. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang Y, Dong J, Sun K, Zhao L, Zhao F,
Wang L and Jiao Y: Obesity and incidence of lung cancer: A
meta-analysis. Int J Cancer. 132:1162–1169. 2013. View Article : Google Scholar
|
|
42
|
Caraballo RS, Giovino GA, Pechacek TF and
Mowery PD: Factors associated with discrepancies between
self-reports on cigarette smoking and measured serum cotinine
levels among persons aged 17 years or older: Third National Health
and Nutrition Examination Survey, 1988–1994. Am J Epidemiol.
153:807–814. 2001. View Article : Google Scholar : PubMed/NCBI
|
